Healthcare (Feb 2023)

Determinants of Acquisition, Persistence, and Clearance of Oncogenic Cervical Human Papillomavirus Infection in the Philippines Using a Multi-Omics Approach: DEFEAT HPV Study Protocol

  • Sheriah Laine M. de Paz-Silava,
  • Ian Kim B. Tabios,
  • Ourlad Alzeus G. Tantengco,
  • Fresthel Monica M. Climacosa,
  • Clarissa L. Velayo,
  • Ryan C. V. Lintao,
  • Leslie Faye T. Cando,
  • Glenmarie Angelica S. Perias,
  • Maria Isabel C. Idolor,
  • Abialbon G. Francisco,
  • Charlene Divine M. Catral,
  • Charlotte M. Chiong,
  • Leslie Michele M. Dalmacio

DOI
https://doi.org/10.3390/healthcare11050658
Journal volume & issue
Vol. 11, no. 5
p. 658

Abstract

Read online

HPV infection is one of the most studied risk factors in cervical cancer—the second most common cancer site and cause of death due to cancer in the Philippines. However, there is a lack of population-based epidemiological data on cervical HPV infection in the Philippines. Local reports on co-infections with other lower genital tract pathogens, commonly reported globally, are also lacking, which emphasizes the need to increase efforts in targeting HPV prevalence, genotype, and distribution. Hence, we aim to determine the molecular epidemiology and natural history of HPV infection among reproductive-age Filipino women using a community-based prospective cohort design. Women from rural and urban centers will be screened until the target sample size of 110 HPV-positive women (55 from rural sites and 55 from urban sites) is reached. Cervical and vaginal swabs will be collected from all screened participants. For HPV-positive patients, HPV genotypes will be determined. One hundred ten healthy controls will be selected from previously screened volunteers. The cases and controls will comprise the multi-omics subset of participants and will be followed up after 6 and 12 months for repeat HPV screening. Metagenomic and metabolomic analyses of the vaginal swabs will also be performed at baseline, after 6 months, and after 12 months. The results of this study will update the prevalence and genotypic distribution of cervical HPV infection among Filipino women, determine whether the current vaccines used for HPV vaccination programs capture the most prevalent high-risk HPV genotypes in the country, and identify vaginal community state types and bacterial taxa associated with the natural history of cervical HPV infection. The results of this study will be used as the basis for developing a biomarker that can help predict the risk of developing persistent cervical HPV infection in Filipino women.

Keywords